The present invention is directed to methods for determining the relative amount of wrongly disulphide bridged TNFR2:Fc in a sample of TNFR2:Fc, a fusion protein which is used in a variety of therapeutic applications. In addition, the invention pertains to a method for purifying TNFR2:Fc using said method for determining the percentage of wrongly disulphide bridged TNFR2:Fc, and to TNFR2:Fc compositions obtained thereby.
本发明涉及确定TNFR2:Fc样品中错误二
硫键连接的TNFR2:Fc相对量的方法,TNFR2:Fc是一种融合蛋白,用于多种治疗应用。此外,本发明还涉及一种利用所述方法纯化 TNFR2:Fc 以确定错误二
硫键连接的 TNFR2:Fc 百分比的方法,以及由此获得的 TNFR2:Fc 组合物。